Par Drugs and Chemicals Limited — Results, 14-02-2025: Integrated Filing- Financial

Par Drugs and Chemicals Limited has announced a board meeting where the unaudited financial results for the quarter and nine months ended December 31, 2024, were approved. Total revenue for the quarter was ₹2,165.29 crore, resulting in a profit of ₹57.80 crore, up from ₹342.22 crore in the previous year. The Board also reviewed corporate governance and the status of investor grievances, noting no outstanding complaints. This solid performance may enhance investor confidence, reflecting positively on the company's ongoing operational effectiveness and governance practices while providing a positive outlook for potential growth.